Literature DB >> 29939175

Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm.

M Carmen Blanco-Gandía1, María A Aguilar1, José Miñarro1, Marta Rodríguez-Arias2.   

Abstract

The present protocol describes the Conditioned Place Preference (CPP) as a model of relapse in drug addiction. In this model, animals are first trained to acquire a conditioned place preference in a drug-paired compartment, and after the post-conditioning test, they perform several sessions to extinguish the established preference. The CPP permits the evaluation of the conditioned rewarding effects of drugs related to environmental cues. Then, the extinguished CPP can be robustly reinstated by the non-contingent administration of a priming dose of the drug, and by exposure to stressful stimuli. Both methods will be explained here. When the animal reinitiates the behavioral response, a reinstatement of the conditioned reward is considered to have taken place. The main advantages of this protocol are that it is non-invasive, inexpensive, and simple with good validity criteria. In addition, it allows the study of different environmental manipulations, such as stress or diet, which can modulate relapse into drug seeking behaviors. However, one limitation is that if the researcher aims to explore the motivation and primary reinforcing effects of the drug, it should be complemented with self-administration procedures, as they involve operant responses of animals.

Entities:  

Mesh:

Year:  2018        PMID: 29939175      PMCID: PMC6101638          DOI: 10.3791/56983

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  41 in total

Review 1.  Conditioned place preference: what does it add to our preclinical understanding of drug reward?

Authors:  M T Bardo; R A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

Review 2.  Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review.

Authors:  Lin Lu; Jack D Shepard; F Scott Hall; Yavin Shaham
Journal:  Neurosci Biobehav Rev       Date:  2003-08       Impact factor: 8.989

Review 3.  Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.

Authors:  David H Epstein; Kenzie L Preston; Jane Stewart; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-22       Impact factor: 4.530

4.  Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants.

Authors:  Yossef Itzhak; Julio L Martin
Journal:  Neuropsychopharmacology       Date:  2002-01       Impact factor: 7.853

Review 5.  Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking.

Authors:  Uri Shalev; Suzanne Erb; Yavin Shaham
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

Review 6.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

7.  The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1978-06-15       Impact factor: 4.530

8.  Genetic liability increases propensity to prime-induced reinstatement of conditioned place preference in mice exposed to low cocaine.

Authors:  Cristina Orsini; Alessandra Bonito-Oliva; David Conversi; Simona Cabib
Journal:  Psychopharmacology (Berl)       Date:  2008-04-18       Impact factor: 4.530

Review 9.  Anti-relapse medications: preclinical models for drug addiction treatment.

Authors:  Noushin Yahyavi-Firouz-Abadi; Ronald E See
Journal:  Pharmacol Ther       Date:  2009-08-13       Impact factor: 12.310

10.  Rhodiola rosea Impairs Acquisition and Expression of Conditioned Place Preference Induced by Cocaine.

Authors:  Federica Titomanlio; Carmen Manzanedo; Marta Rodríguez-Arias; Laura Mattioli; Marina Perfumi; José Miñarro; María A Aguilar
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.